Why the study?
New ESC guidelines on heart failure, atrial fibrillation, dyslipidemia, and cardiovascular prevention were presented to update management recommendations and improve clinical practice implementation.
Cohort (n=1,007)
Yes
Hazard Ratio: 1.162 (95% CI 1.073–1.259)
p-value: p=<0.001
During the ESC congress in September 2016 in Rome, the new ESC guidelines were presented and are now available on the ESC website ( http://www.escardio.org/guidelines ). The new guidelines cover management recommendations on following cardiovascular items: Heart failure, atrial fibrillation, dyslipidemia and cardiovascular prevention. The present document gives a summary of these guidelines and highlights the most important recommendations and changes in the management of these diseases. It will help to increase awareness about the new guidelines and may stimulate to consult the full document for specific items. Ultimately, the authors hope that this document will enhance implementation of new ESC guidelines in daily clinical practice.
No takes yet. Share an insight, caveat, or question.
Claeys et al. (2017) conducted a cohort in Obstructive sleep apnea syndrome (OSAS) (n=1,007). Serum total bilirubin (TBil) ≥ 11.5 µmol/L vs. Serum total bilirubin (TBil) < 11.5 µmol/L was evaluated on First incident stroke (ischemic or hemorrhagic) (HR 1.162, 95% CI 1.073-1.259, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: